These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8192687)

  • 1. Cannabinoid receptors: G-protein-mediated signal transduction mechanisms.
    Childers SR; Pacheco MA; Bennett BA; Edwards TA; Hampson RE; Mu J; Deadwyler SA
    Biochem Soc Symp; 1993; 59():27-50. PubMed ID: 8192687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid signalling.
    Demuth DG; Molleman A
    Life Sci; 2006 Jan; 78(6):549-63. PubMed ID: 16109430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
    Basavarajappa BS; Hungund BL
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid mu, delta, and kappa receptor-induced activation of phospholipase C-beta 3 and inhibition of adenylyl cyclase is mediated by Gi2 and G(o) in smooth muscle.
    Murthy KS; Makhlouf GM
    Mol Pharmacol; 1996 Oct; 50(4):870-7. PubMed ID: 8863832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of cannabinoid receptors in cultures of rat cerebellar granule cells.
    Pacheco MA; Ward SJ; Childers SR
    Brain Res; 1993 Feb; 603(1):102-10. PubMed ID: 8384043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids.
    McAllister SD; Glass M
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):161-71. PubMed ID: 12052033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional neuroanatomy of brain cannabinoid receptors.
    Breivogel CS; Childers SR
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):417-31. PubMed ID: 9974175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SR144528 as inverse agonist of CB2 cannabinoid receptor.
    Rhee MH; Kim SK
    J Vet Sci; 2002 Sep; 3(3):179-84. PubMed ID: 12514329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of a highly conserved aspartate residue in the second transmembrane domain of the cannabinoid receptors, CB1 and CB2, disrupts G-protein coupling.
    Tao Q; Abood ME
    J Pharmacol Exp Ther; 1998 May; 285(2):651-8. PubMed ID: 9580609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CB1 cannabinoid receptor in the brain.
    Howlett AC
    Neurobiol Dis; 1998 Dec; 5(6 Pt B):405-16. PubMed ID: 9974174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptors: where they are and what they do.
    Mackie K
    J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of cannabinoid receptors.
    Howlett AC
    Annu Rev Pharmacol Toxicol; 1995; 35():607-34. PubMed ID: 7598509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular effects of cannabinoids.
    Martin BR
    Pharmacol Rev; 1986 Mar; 38(1):45-74. PubMed ID: 2872689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid receptors and their ligands.
    Pertwee RG; Ross RA
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid signalling in the enteric nervous system.
    Galligan JJ
    Neurogastroenterol Motil; 2009 Sep; 21(9):899-902. PubMed ID: 19689654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of cyclic AMP in the actions of cannabinoid receptors.
    Childers SR; Deadwyler SA
    Biochem Pharmacol; 1996 Sep; 52(6):819-27. PubMed ID: 8781498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term administration of Delta9-tetrahydrocannabinol desensitizes CB1-, adenosine A1-, and GABAB-mediated inhibition of adenylyl cyclase in mouse cerebellum.
    Selley DE; Cassidy MP; Martin BR; Sim-Selley LJ
    Mol Pharmacol; 2004 Nov; 66(5):1275-84. PubMed ID: 15286206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.